196707-32-1

Basic information

• Product Name: (R)-N-BOC-4-FLUOROPHENYLGLYCINE
• Synonyms: (D)-N-TERT-BUTOXYCARBONYL-ALPHA-(4-FLUOROPHENYL)ACETIC ACID;BOC-4-FLUORO-D-PHENYLGLYCINE;(R)-N-boc-4-Fluorophenylglycine(e.e.);(R)-N-BOC-4-FLUOROPHENYLGLYCINE 95% (98% E.E.);(R)-N-Boc-4-fluorophenylglycine, 95%, ee:98%;(R)-N-BOC-4-Fluorophenylglycine, 98% ee;(R)-N-BOC-4-Fluorophenylglycine, 98% ee, 95% 1GR;Boc-(R)-2-amino-2-(4-fluorophenyl)acetic acid
• CAS NO: 196707-32-1
• Molecular Formula: C₁₃H₁₆FNO₄
• Molecular Weight: 269.27
• Mol File: 196707-32-1.mol
• Article Data: 4

Chemical Properties

• Melting Point: 85.7 °C
• Boiling Point: 408.4°Cat760mmHg
• Flash Point: 200.8°C
• Appearance: White/Powder
• Density: 1.2168 (estimate)
• Vapor Pressure: 2.1E-07mmHg at 25°C
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.47±0.10(Predicted)
• CAS DataBase Reference: (R)-N-BOC-4-FLUOROPHENYLGLYCINE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-N-BOC-4-FLUOROPHENYLGLYCINE(196707-32-1)
• EPA Substance Registry System: (R)-N-BOC-4-FLUOROPHENYLGLYCINE(196707-32-1)

Safety Data

• Safety Statements: 24/25
• HazardClass: IRRITANT
• Hazardous Substances Data: 196707-32-1(Hazardous Substances Data)

Usage

Chemical Properties

white powder

InChI:InChI=1/C13H16FNO4/c1-13(2,3)19-12(18)15-10(11(16)17)8-4-6-9(14)7-5-8/h4-7,10H,1-3H3,(H,15,18)(H,16,17)/p-1/t10-/m1/s1

Upstream product

• 124-38-9 carbon dioxide 
• 196707-30-9 N-(trimethylsilyl)-N-(tert-butyloxycarbonyl)-4-fluorobenzylamine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 140-75-0 para-fluorobenzylamine 
• 153903-23-2 (4-fluorobenzyl)carbamic acid tert-butyl ester 
• 351-95-1 N-(4-fluoro-phenyl)-glycine 
• 93939-74-3 (R)-2-(4-fluorophenyl)glycine 

Downstream Products

• 1001413-74-6 [(R)-1-(4-fluorophenyl)-2-hydroxyethyl]carbamic acid tert-butyl ester 
• 170902-76-8 methyl (R)-amino-(4-fluorophenyl)-acetate 
• 1227811-15-5 (S)-prop-2-ynyl 2-(tert-butoxycarbonylamino)-2-(4-fluorophenyl)acetate 
• 1443764-09-7 tert-butyl [(1R)-1-(4-fluorophenyl)-2-{[4-(2-{[2-methoxy-4-(methylsulfonyl)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]amino}-2-oxoethyl]carbamate 

Relevant articles and documents

PIPERAZINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT

The present inventions relate to substituted piperazine derivatives of general formula (I) and to the manufacture of said compounds, pharmaceutical compositions comprising a compound according to general formula (I), and the use of said compounds for the treatment of various medical conditions related to glycine transporter-1 (GlyT1).

Rapid access to N-Boc phenylglycine derivatives via benzylic lithiation reactions

We report a novel and efficient method for the enantioselective synthesis of N-Boc protected phenylglycines. Yields and enantiomeric ratios vary widely depending on the nature of the solvent, the substrate and on the method of forming the chiral complex. Results show that the major reaction pathway is an enantioselective deprotonation/substitution process. The enantioselectivity appears to be limited by the chiral discrimination ability of the s-BuLi-(-)-sparteine complex. The synthetic method described is one of the shortest route to useful enantioenriched N-Boc phenylglycine derivatives.